Polymorphisms of the methylenetetrahydrofolate reductase, vascular endothelial growth factor, endothelial nitric oxide synthase, monocyte chemoattractant protein-1 and apolipoprotein E genes are not associated with carotid intima-media thickness

Canadian Journal of Cardiology

Volumn 25, Issue 1, 2009, Pages

  Alioglu, Emin ^a   Turk, Ugur ^a   Cam, Sirri ^b   Abbasaliyev, Abbasali ^c   Tengiz, Istemihan ^a   Ercan, Ertugrul ^a  

^a Central Hospital Izmir   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c Central Hospital for Oilworkers   (Azerbaijan)

Author keywords

Atherosclerosis related genes; Carotid intima media thickness; Coronary artery disease; Homocysteine

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN E; C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HOMOCYSTEINE; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ADULT; AMINO ACID BLOOD LEVEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

EID: 60849131494     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70022-4     Document Type: Article

References (48)

1. Wong M, Edelstein J, Wollman J, Bond MG. Ultrasonic-pathological comparison of the human arterial wall: Verification of intima-media thickness. Arterioscler Thromb 1993;13:482-6.
2. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993;87:II56-65.
3. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94.
4. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 1997;96:1432-7.
5. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-9.
6. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: Prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006;37:87-92.
7. Dijk JM, van der Graaf Y, Bots ML, Grobbee DE, Algra A. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: The SMART study. Eur Heart J 2006;27:1971-8.
8. Manolio TA, Boerwinkle E, O'Donnell CJ, Wilson AF. Genetics of ultrasonographic carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:1567-77.
9. Howell WM, Ali S, Rose-Zerilli MJ, Ye S. VEGF polymorphisms and severity of atherosclerosis. J Med Genet 2005;42:485-90.
10. Szalai C, Duba J, Prohaszka Z, et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD): Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 2001;158:233-9.
11. Crouse JR III. Predictive value of carotid 2-dimensional ultrasound. Am J Cardiol 2001;88(Suppl):27E-30E.
12. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A. A common variant of the endothelial nitric oxide synthase (Glu298-Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999;100:1515-20.
13. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999;259:344-8.
14. Watson CJ, Webb NJA, Bottomley MJ, Brenchley PEC. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine 2000;12:1232-5.
15. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 2003;111:84-90.
16. Wenham PR, Price WH, Blundel G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-9.
17. Turkish Society of Cardiology. TEKHARF study: Turkish Heart Report 2000. Istanbul: Yenilik Publication, 2000:11-25.
18. Kang SS, Wong PW. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis 1996;119:135-8.
19. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM. Plasma concentration of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr 1994;124:1934-41.
20. Kablak-Ziembicka A, Tracz W, Przewlocki T, Pieniazek P, Sokolowski A, Konieczynska M. Association of increased carotid intima-media thickness with the extent of coronary artery disease. Heart 2004;90:1286-90.
21. Graner M, Varpula M, Kahri J, et al. Association of carotid intima-media thickness with angiographic severity and extent of coronary artery disease. Am J Cardiol 2006;97:624-9.
22. Crouse JR, Craven TE, Hagaman AP, et al. Association of coronary disease with segment-specific intimal-media thickening of the extracranial carotid artery. Circulation 1995;92:1141-7.
23. Venugopal SK, Devaraj S, Jialal I. Effect of C-reactive protein on vascular cells: Evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens 2005;14:33-7.
24. del Sol IA, Bots ML, Grobbee DE, Hofman A, Witteman JC. Carotid intima-media thickness at different sites: Relation to incident myocardial infarction. The Rotterdam study. Eur Heart J 2002;23:934-40.
25. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: A new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002;20:159-69.
26. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-81.
27. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-8.
28. Van den Berg M, Stehouwer CD, Bierdrager E, Rauwerda JA. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease. Arterioscler Thromb Vasc Biol 1996;16:165-71.
29. Jacobsen DW, Catanescu O, Dibello PM, Barbato JC. Molecular targeting by homocysteine: A mechanism for vascular pathogenesis. Clin Chem Lab Med 2005;43:1076-83.
30. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
31. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening: The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 1999;99:2383-8.
32. Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56:142-50.
33. Harmon DL, Woodside JV, Yarnell JWG, et al. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. Q J Med 1996;89:571-7.
34. Mazza A, Motti C, Nulli A, et al. Lack of association between carotid intima-media thickness and methylenetetrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin-dependent diabetes mellitus. Metabolism 2000;49:718-23.
35. Kang SS, Wong PW. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis 1996;119:135-8.
36. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM. Plasma concentration of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr 1994;124:1934-41.
37. Lembo G, De Luca N, Battagli C, et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 2001;32:735-40.
38. Karvonen J, Kauma H, Kervinen K, et al. Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 2002;251:102-10.
39. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: A huge review. Am J Epidemiol 2002;155:487-95.
40. de Andrade M, Thandi I, Brown S, Gotto A Jr, Patsch W, Boerwinkle E. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet 1995;56:1379-90.
41. Hanon O, Girerd X, Luong V, Jeunemaitre X, Laurent S, Safar ME. Association between the apolipoprotein E polymorphism and arterial wall thickness in asymptomatic adults. J Hypertens 2000;18:431-6.
42. Zannad F, Visvikis S, Gueguen R, et al. Genetics strongly determines the wall thickness of the left and right carotid arteries. Hum Genet 1998;103:183-8.
43. Djousse L, Myers RH, Province MA, et al. Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke 2002;33:1357-61.
44. Sass C, Zannad F, Herbeth B, et al. Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort. Atherosclerosis 1998;140:89-95.
45. Horejsi B, Spacil J, Ceska R, Vrablik M, Haas T, Horinek A. The independent correlation of the impact of lipoprotein(a) levels and apolipoprotein E polymorphism on carotid artery intima thickness. Int Angiol 2000;1919:331-6.
46. Kogawa K, Nishizawa Y, Hosoi M, et al. Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness. Diabetes 1997;46:682-7.
47. Schmidt AM, Stern DM. Chemokine on the rise: MCP-1 and restenosis. Arterioscler Thromb Vasc Biol 2001;21:297-9.
48. Tabara Y, Kohara K, Yamamoto Y, et al. Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 2003;26:677-83.